Cargando…

Design and profile of low-molecular-weight receptor tyrosine kinase inhibitors for antiangiogenic therapy

Detalles Bibliográficos
Autor principal: Wood, JM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300586/
http://dx.doi.org/10.1186/bcr403
_version_ 1782226312659730432
author Wood, JM
author_facet Wood, JM
author_sort Wood, JM
collection PubMed
description
format Online
Article
Text
id pubmed-3300586
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33005862012-03-14 Design and profile of low-molecular-weight receptor tyrosine kinase inhibitors for antiangiogenic therapy Wood, JM Breast Cancer Res Meeting Abstract BioMed Central 2001 2001-05-29 /pmc/articles/PMC3300586/ http://dx.doi.org/10.1186/bcr403 Text en Copyright ©2001 BioMed Central Ltd
spellingShingle Meeting Abstract
Wood, JM
Design and profile of low-molecular-weight receptor tyrosine kinase inhibitors for antiangiogenic therapy
title Design and profile of low-molecular-weight receptor tyrosine kinase inhibitors for antiangiogenic therapy
title_full Design and profile of low-molecular-weight receptor tyrosine kinase inhibitors for antiangiogenic therapy
title_fullStr Design and profile of low-molecular-weight receptor tyrosine kinase inhibitors for antiangiogenic therapy
title_full_unstemmed Design and profile of low-molecular-weight receptor tyrosine kinase inhibitors for antiangiogenic therapy
title_short Design and profile of low-molecular-weight receptor tyrosine kinase inhibitors for antiangiogenic therapy
title_sort design and profile of low-molecular-weight receptor tyrosine kinase inhibitors for antiangiogenic therapy
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300586/
http://dx.doi.org/10.1186/bcr403
work_keys_str_mv AT woodjm designandprofileoflowmolecularweightreceptortyrosinekinaseinhibitorsforantiangiogenictherapy